Conway Stuart Medical, Inc. Changes Name, Becomes Curon Medical, Inc.

Business Editors and Health/Medical Writers

SUNNYVALE, Calif.--(BW HealthWire)--March 14, 2000

Effective today, Conway Stuart Medical, Inc., the developer of cutting edge treatments for gastrointestinal disorders, has changed its name to Curon Medical, Inc. The change was made to better communicate the company's ongoing mission to develop treatments for gastrointestinal disorders, including gastroesophageal reflux disease or GERD. The Stretta(TM)System, the company's initial product offering, which is currently under evaluation by the FDA, is a device that uses radiofrequency energy to treat GERD. The Stretta Procedure is minimally invasive and performed in an outpatient setting.

"The name Curon Medical reflects our continued focus on developing innovative treatments for gastrointestinal disorders," said John W. Morgan, President and Chief Executive Officer of Curon Medical, Inc. "The change was made to capture the excitement and potential of our therapies, and comes at a critical stage in the company's development as we await a decision from the FDA on the Stretta Procedure." The company will use www.curonmedical.com as its new domain address.

About Curon Medical, Inc.

Curon Medical, Inc. (formerly Conway Stuart Medical, Inc.) of Sunnyvale, Calif., is focused on developing cutting edge technology therapies using radiofrequency energy for the treatment of gastrointestinal disorders. The Company's initial product offering, the Stretta(TM)System, is a minimally invasive treatment for gastroesophageal reflux disease or GERD. The Stretta Procedure has CE Mark approval for use in Europe. The Stretta Procedure is performed on an outpatient basis in 60 minutes or less by a gastroenterologist. Most Stretta patients are able to return to normal activity the following day. Curon Medical can be found on the Web at www.curonmedical.com.